Novel long-acting ropeginterferon alfa-2b: Pharmacokinetics, pharmacodynamics and safety in a phase I clinical trial

Yi Wen Huang, Albert Qin, Jane Fang, Ting Fang Wang, Chung Wei Tsai, Ko Chung Lin, Ching Leou Teng, Richard Larouche

Research output: Contribution to journalArticlepeer-review

1 Citation (Scopus)

Fingerprint

Dive into the research topics of 'Novel long-acting ropeginterferon alfa-2b: Pharmacokinetics, pharmacodynamics and safety in a phase I clinical trial'. Together they form a unique fingerprint.

Medicine & Life Sciences